FDA Drug Approvals: Time Is Money

We investigated the stock price behavior of public pharmaceutical and biotechnology companies upon approval of a drug by the Food and Drug Administration (FDA). Using event study methodology, we examine the reaction caused by the approval, separating it from the asset price movements caused by other...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	The journal of entrepreneurial finance 2007-12, Vol.12 (2), p.23-54
Hauptverfasser:	Sturm, Andreas, Dowling, Michael J., Röder, Klaus
Format:	Artikel
Sprache:	eng
Schlagworte:	Abnormal returns Biotechnology industry Cash flow Drugs Efficient markets FDA approval Hypotheses Pharmaceutical industry Stock exchanges Stock prices Studies
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!